Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now
Quote Panel
Key Metrics
Fundamentals
Relative Strength
BIAFW
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
|---|---|---|---|
Forecast
Analyst rating
Last analyst upgrade/downgrade
Earnings Growth
YoY
Current
Estimates
Q3.22
N/A
NA
vs NA
Q4.22
N/A
NA
vs NA
Q1.23
N/A
-0.00
vs NA
Q2.23
N/A
-0.00
vs NA
Q3.23
N/A
-0.00
vs NA
Q4.23
N/A
NA
vs NA
Q1.24
N/A
NA
vs -0.00
Q2.24
N/A
NA
vs -0.00
Q3.24
N/A
NA
vs -0.00
Q4.24
N/A
NA
vs NA
Sales Growth
YoY
Current
Estimates
Q4.22
NA
2.3K vs NA
Q1.23
NA
921 vs NA
Q2.23
+1411%
19.7K vs 1.3K
Q3.23
+25855%
298.5K vs 1.1K
Q4.23
+94246%
2.2M vs 2.3K
Q1.24
+261180%
2.4M vs 921
Q2.24
+12047%
2.4M vs 19.7K
Q3.24
+687%
2.4M vs 298.5K
Q4.24
0%
2.2M vs 2.2M
Q1.25
-12%
2.1M vs 2.4M
Return on Equity
QoQ
Q1.23
-16%
-0.16
vs -0.15
Q2.23
-21%
-0.21
vs -0.16
Q3.23
-33%
-0.33
vs -0.21
Q4.23
-49%
-0.49
vs -0.33
Q1.24
-37%
-0.37
vs -0.49
Q2.24
-61%
-0.61
vs -0.37
Q3.24
-64%
-0.64
vs -0.61
Q4.24
-114%
-1.14
vs -0.64
Institutionnal Ownership
Quote Panel
Key Metrics
Forecast
174%2025-Revenue
61%2025-EBITDA
Analyst rating
Strong Sell
Sell
Buy
Neutral
Strong Buy
Price Target
NaN(-100.00%)
Number of analyst
Last analyst upgrade/downgrade
No Data Available
Relative Strength
BIAFW
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
|---|---|---|---|
bioAffinity Technologies, Inc. operates as a development-stage company addressing the significant unmet need for non-invasive, early-stage cancer diagnosis and treatment. The firm develops proprietary in-vitro diagnostic tests and targeted cancer therapeutics using breakthrough technology that preferentially targets cancer cells. The company was founded on March 26, 2014 and is headquartered in San Antonio, TX.
NASDAQ
-0.03Â ( -14.45%)
Relative Strenght
14
Volume Buzz
-61%
Earning Acce
No
Dist 52w H.
17%